Allarity Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALLR research report →
About the company
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics.
- CEO
- Thomas H. Jensen
- IPO
- 2021
- Employees
- 6
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $20.84M
- P/E
- -1.86
- P/S
- 60.41
- P/B
- 3.02
- EV/EBITDA
- -2.06
- Div Yield
- 0.00%
- Gross Margin
- 107.54%
- Op Margin
- -3552.75%
- Net Margin
- -3260.58%
- ROE
- -109.94%
- ROIC
- -43.13%
- Revenue
- $320.00K · 0.00%
- Net Income
- $-11,231,000 · 54.19%
- EPS
- $-0.78 · 95.06%
- Op Income
- $-12,605,000
- FCF YoY
- 15.99%
- 52W High
- $2.35
- 52W Low
- $0.77
- 50D MA
- $1.47
- 200D MA
- $1.28
- Beta
- 0.52
- Avg Volume
- 196.45K
Get TickerSpark's AI analysis on ALLR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 28, 26 | Jensen Thomas | other | 200,000 |
| Jan 7, 26 | Hoeiland Jesper | other | 25,000 |
| Jun 10, 25 | Hoeiland Jesper | other | 0 |
| Jan 28, 26 | McLaughlin Gerald W. | other | 45,000 |
| Jan 28, 26 | Graff Jeremy R. | other | 133,333 |
| Jan 28, 26 | Ervin Jeffrey S | other | 150,000 |
| Jan 7, 26 | Graff Jeremy R. | other | 133,333 |
| Sep 30, 25 | Graff Jeremy R. | other | 39,494 |
| Sep 30, 25 | Graff Jeremy R. | other | 39,494 |
| Sep 30, 25 | Graff Jeremy R. | other | 14,613 |
Our ALLR coverage
Recent articles, reports, and earnings notes.
No research on ALLR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALLR report →Similar companies
Peers in the same neighborhood.